BA
QDEL icon

Boston Advisors’s QuidelOrtho QDEL Stock Holding History

Boston Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,405
Closed -$711K – 662
2017
Q4 		$711K Buy
16,405
+425
+3% +$17.4K 0.02% 433
2017
Q3 		$701K Sell
15,980
-3,200
-17% -$111K 0.02% 422
2017
Q2 		$521K Buy
+19,180
New +$475K 0.01% 488

Other funds holding QDEL

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Boston Advisors's QDEL Position: Q1 2018 in Review

Boston Advisors sold out of QuidelOrtho (QDEL) in Q1 2018, closing a stake of 16,405 shares — an estimated $711K sold.

Boston Advisors first reported a position in QDEL in Q2 2017 and held it in 3 quarters. The position peaked at $711K in Q4 2017. 148 funds tracked by Wall St. Rank hold QDEL as of Q1 2018.

  • Boston Advisors reported no remaining QuidelOrtho position as of Q1 2018 after selling out during the quarter.
  • Boston Advisors sold 16,405 QuidelOrtho shares in Q1 2018, an estimated $711K.
  • Boston Advisors first reported a position in QuidelOrtho in Q2 2017 and held it in 3 quarters.
  • Boston Advisors's QuidelOrtho position peaked at $711K in Q4 2017.
  • 148 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.